The Wikipedia page for Doctor Calvin Knowlton is being searched for. He is an accomplished healthcare leader with a strong educational background and a wealth of knowledge and expertise.
He has worked in the pharmaceutical field his whole professional life, gaining a plethora of knowledge and honing his skills in the process.
As Chairperson and CEO of Tabula Rasa HealthCare (TRHC), a pioneering business focusing on pharmaceutical risk prevention, Dr. Knowlton held a noteworthy position.
Since its founding in 2009, TRHC has established itself as the industry leader in the development of patient-specific, data-driven technologies and solutions.
His patented technique, MedWise, is essential for spotting accumulating multi-drug interactions and removing related side effects.
Additional solutions that assist pharmacists in reducing risk and being rewarded for their jobs include CareKinesis, RxCompanion, and Medilance.
Wikipedia bio for Calvin Knowlton Age
Page Contents
Dr. Calvin has spent more than three decades making important contributions to the worlds of pharmacy, industry, and charity.
Although his precise age is still unclear, he seems like he could be in his 70s.
Dr. Knowlton’s educational history demonstrates his dedication to knowledge and lifelong learning. He graduated from Princeton Theological Seminary with a divinity degree and Temple University with a pharmacy degree.
He served as a professor and the department chair at Philadelphia’s University of the Sciences in the 1990s. He had a significant impact on the pupils and the school.
The physician graduated with a Ph.D. in pharmacoeconomics from UMSOP in 1993, and in 2017 the organization honored him as one of its prestigious Founding Pharmapreneurs.
He has received several honors, including the 1997 title of Most Influential Pharmacist in the United States.
He was also recognized in 2004 as the Walter M. Aikman Entrepreneur of the Year.
When he received the coveted Remington Honor Medal in 2015—the highest honor given by the American Pharmacists Association (APhA)—his accomplishments were further acknowledged.
Wife of Calvin Knowlton
Together with his devoted wife, Dr. Orsula V. Knowlton, Dr. Calvin discusses his life’s story. These two strong people care deeply for one another and their eight amazing kids.
A significant portion of Dr. Orsula V. Knowlton’s professional career has been devoted to the healthcare sector, notably in cosmopolitan Philadelphia, Pennsylvania.
She has an excellent history that spans more than 25 years, and she has developed into a seasoned authority on pharmaceutical safety and the pharmacy industry.
Dr. Calvin Knowlton and his wife, Dr. Orsula V. Knowlton, according to Forbes
She was a founding member of the ground-breaking healthcare company Tabula Rasa Healthcare, Inc., which was established in 2005.
As President, Chief Marketing and New Business Development Officer, Chief Diversity and Inclusion Officer, and President of the Board of Directors throughout her time at Tabula Rasa Healthcare, Inc., Dr. Orsula filled key positions.
Orsula Knowlton has maintained current by obtaining the required authorizations and licenses. In the states of New Jersey, Pennsylvania, and Virginia, she is a licensed pharmacist.
Calvin Knowlton’s net worth is amazing, at over $4 million, and it may become much higher shortly. He is the CEO and owner of Tabula Rasa Healthcare Inc.
He has about 693,213 shares of Tabula Rasa HealthCare Inc. (TRHC) valued at more than $4 million as of December 23, 2021.
Since its founding in 2009, TRHC has established itself as a leading supplier of data-driven, patient-specific technologies and solutions that enable pharmacists to improve drug regimens.
With over 1,700 team members, including more than 400 board-certified PharmDs, the firm currently has over 1,700 employees thanks to Doctor Calvin’s successful attempt to take TRHC public in September 2016.
TRHC has over $300 million in sales, making it the market leader. Amazingly, Dr. Calvin has run 10 different businesses.
Doctor served as the Chair and CEO of Hospice Pharmacy before being involved with TRHC. Over 800 hospice programs and 85,000 hospice patients nationally received drug management systems from the firm during his leadership, which saw sales of $250 million.
Also Read: Is Deadliest Catch’s Josh Harris Wed? Family And Wealth
